Where Do Our Products Come From?

Taking into consideration ethical concerns and religious sensitivities, our products are derived solely from the Wharton's Jelly layer collected from human baby umbilical cord tissue - wjMSCs. It is collected after a baby is born and the umbilical cord is cut. This guarantees that both mother and baby are safe ^[1]. All our products are sourced from Malaysian births that have exceeded 37 weeks gestation.

Why Age Matters

MSCs from older sources lose the ability to differentiate and increase the likelihood of contamination by viruses, diseases, toxins and mutations. They also increase the chances of a negative immune response and rejection.

A younger source means longer survival duration and higher proliferation rate. Umbilical cord-derived products - such as Wharton's Jelly MSCs - are the purest and youngest tissue-specific sources available. It does not require perfect HLA tissue matching and has fewer incidents of immune rejection. Because of this characteristic, it is ideal for allogeneic (donor) transfusions ^[2,3]. Its use in therapy poses no danger or discomfort to the patient. 

Quality & Efficacy

At Cyrona, we make it a priority to ensure that our patients are given only the highest quality products as well as the best chances of treatment with minimum to no side effects. As such, we produce only premium grade passage 2 wjMSCs for your treatment.

All our therapeutics are produced in accordance with stringent Standard Operating Procedures. Our specially formulated products are prepared in a Biosafety Level 2 workspace. Each batch is bar-coded according to batch number, for quality assurance purposes, then analysed for morphology, genomics and proteomics before cryopreservation at an ultra-low temperature of -196 °C. Post-treatment, each patient is provided with a detailed Certificate of Analysis for their recordkeeping.